Asensus Surgical, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Asensus Surgical, Inc. (NYSE American: ASXC) will present at the 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023, at 12:00 PM PST. This event aims to showcase the company's innovative approach to Performance-Guided Surgery, utilizing advanced technology to improve surgical outcomes. The presentation will be accessible via a live audio webcast on the company's investor page, with replays available for 30 days. Asensus Surgical focuses on enhancing surgeon control and reducing variability using the Senhance Surgical System.

RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the management team will participate and present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 12:00 PM PST.

Event: 41st Annual J.P. Morgan Healthcare Conference

Date: Thursday, January 12, 2023

Time: 12:00 PM PST

A live audio webcast of the conference presentation will be available online on the investor relations page of the Company’s website at https://ir.asensus.com/events-and-presentations. Replays of the webcasts will be archived on the website for approximately 30 days.

About Asensus Surgical, Inc.

Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.

Follow Asensus

Email Alerts: https://ir.asensus.com/email-alerts

LinkedIn: https://www.linkedin.com/company/asensus-surgical-inc

Twitter: https://twitter.com/AsensusSurgical

YouTube: https://www.youtube.com/c/transenterix

Vimeo: https://vimeo.com/asxc

TikTok: https://www.tiktok.com/@asensus_surgical

INVESTOR CONTACT:
Mark Klausner or Mike Vallie, 443-213-0499
invest@asensus.com

MEDIA CONTACT:
Isabella Rodriguez, 708-833-1572
CG Life
irodriguez@cglife.com

FAQ

When will Asensus Surgical present at the J.P. Morgan Healthcare Conference?

Asensus Surgical will present on January 12, 2023, at 12:00 PM PST.

Where can I watch Asensus Surgical's presentation at the J.P. Morgan Healthcare Conference?

The presentation will be available via a live audio webcast on the investor relations page of Asensus Surgical's website.

What is the focus of Asensus Surgical's presentation at the J.P. Morgan Healthcare Conference?

The presentation will focus on Performance-Guided Surgery and the use of the Senhance Surgical System.

What is the stock symbol for Asensus Surgical?

The stock symbol for Asensus Surgical is ASXC.

How long will the webcast of Asensus Surgical's presentation be available?

The webcast will be archived and available for replay for approximately 30 days.